{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:59:58Z","timestamp":1790539198682,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","thegreenjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.radonc.2017.08.010","type":"journal-article","created":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T12:45:29Z","timestamp":1503492329000},"page":"533-540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":132,"title":["Residual tumour hypoxia in head-and-neck cancer patients undergoing primary radiochemotherapy, final results of a prospective trial on repeat FMISO-PET imaging"],"prefix":"10.1016","volume":"124","author":[{"given":"Steffen","family":"L\u00f6ck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalind","family":"Perrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annekatrin","family":"Seidlitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bandurska-Luque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Zschaeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Z\u00f6phel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mechthild","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Steinbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Kotzerke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Zips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther G.C.","family":"Troost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2017.08.010_b0050","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJMra0910283","article-title":"Hypoxia and inflammation","volume":"364","author":"Eltzschig","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2017.08.010_b0100","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2012.171","article-title":"Imaging hypoxia to improve radiotherapy outcome","volume":"9","author":"Horsman","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.radonc.2017.08.010_b0155","doi-asserted-by":"crossref","first-page":"C569","DOI":"10.1152\/ajpcell.00207.2015","article-title":"Hypoxia: a key player in antitumor immune response. a review in the theme: cellular responses to hypoxia","volume":"309","author":"Noman","year":"2015","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.radonc.2017.08.010_b0180","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0305-7372(03)00003-3","article-title":"Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies","volume":"29","author":"Shannon","year":"2003","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.radonc.2017.08.010_b0125","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1158\/1078-0432.CCR-15-1990","article-title":"Low cancer stem cell marker expression and low hypoxia identify good prognosis subgroups in HPV(-) HNSCC after postoperative radiochemotherapy: a multicenter study of the DKTK-ROG","volume":"22","author":"Linge","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2017.08.010_b0250","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10555-007-9055-1","article-title":"Hypoxia in cancer: significance and impact on clinical outcome","volume":"26","author":"Vaupel","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.radonc.2017.08.010_b0105","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1200\/JCO.2011.35.9315","article-title":"Accelerated radiotherapy with carbogen and nicotinamide for laryngeal cancer: results of a phase III randomized trial","volume":"30","author":"Janssens","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2017.08.010_b0160","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.radonc.2011.03.004","article-title":"Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck\u2013a systematic review and meta-analysis","volume":"100","author":"Overgaard","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.08.010_b0075","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1259\/0007-1285-39-460-302","article-title":"Extreme hypoxia; its effect on the survival of mammalian cells irradiated at high and low dose-rates","volume":"39","author":"Hall","year":"1966","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2017.08.010_b0120","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0360-3016(00)00467-3","article-title":"Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality","volume":"47","author":"Ling","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2017.08.010_b0165","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.radonc.2009.02.020","article-title":"Metabolic control probability in tumour subvolumes or how to guide tumour dose redistribution in non-small cell lung cancer (NSCLC): an exploratory clinical study","volume":"91","author":"Petit","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.08.010_b0170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.radonc.2014.02.005","article-title":"Effect of [(18)F]FMISO stratified dose-escalation on local control in FaDu hSCC in nude mice","volume":"111","author":"Schutze","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.08.010_b0015","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrc.2016.18","article-title":"Radiation oncology in the era of precision medicine","volume":"16","author":"Baumann","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.radonc.2017.08.010_b0045","doi-asserted-by":"crossref","first-page":"14620","DOI":"10.1073\/pnas.1102526108","article-title":"Preclinical evaluation and validation of [18F]HX4, a promising hypoxia marker for PET imaging","volume":"108","author":"Dubois","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.radonc.2017.08.010_b0095","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1016\/j.ejca.2009.07.012","article-title":"Hypoxia in larynx carcinomas assessed by pimonidazole binding and the value of CA-IX and vascularity as surrogate markers of hypoxia","volume":"45","author":"Hoogsteen","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2017.08.010_b0110","doi-asserted-by":"crossref","first-page":"20150014","DOI":"10.1259\/bjr.20150014","article-title":"Validation of functional imaging as a biomarker for radiation treatment response","volume":"88","author":"Jentsch","year":"2015","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2017.08.010_b0185","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.radonc.2015.06.028","article-title":"The usability of a 15-gene hypoxia classifier as a universal hypoxia profile in various cancer cell types","volume":"116","author":"Sorensen","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.08.010_b0195","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.radonc.2006.07.033","article-title":"Combined uptake of [18F]FDG and [18F]FMISO correlates with radiation therapy outcome in head-and-neck cancer patients","volume":"80","author":"Thorwarth","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.08.010_b0220","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.radonc.2014.12.015","article-title":"Predictive value of (18)F-FAZA PET imaging for guiding the association of radiotherapy with nimorazole: a preclinical study","volume":"114","author":"Tran","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.08.010_b0235","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.2967\/jnumed.115.162529","article-title":"Imaging-based treatment adaptation in radiation oncology","volume":"56","author":"Troost","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.radonc.2017.08.010_b0270","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1007\/s00259-016-3429-y","article-title":"Evaluation of tumour hypoxia during radiotherapy using [18F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer","volume":"43","author":"Zegers","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.radonc.2017.08.010_b0275","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.1158\/1078-0432.CCR-14-1524","article-title":"In vivo quantification of hypoxic and metabolic status of NSCLC tumors using [18F]HX4 and [18F]FDG-PET\/CT imaging","volume":"20","author":"Zegers","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2017.08.010_b0055","first-page":"253","article-title":"Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy","volume":"46","author":"Eschmann","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.radonc.2017.08.010_b0200","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ijrobp.2006.11.061","article-title":"Hypoxia dose painting by numbers: a planning study","volume":"68","author":"Thorwarth","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2017.08.010_b0205","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1088\/0031-9155\/50\/10\/002","article-title":"A kinetic model for dynamic [18F]-FMISO PET data to analyse tumour hypoxia","volume":"50","author":"Thorwarth","year":"2005","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2017.08.010_b0040","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/hed.10177","article-title":"Prognostic impact of reoxygenation in advanced cancer of the head and neck during the initial course of chemoradiation or radiotherapy alone","volume":"25","author":"Dietz","year":"2003","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2017.08.010_b0135","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1667\/RR0719.1","article-title":"Dynamics of tumor hypoxia measured with bioreductive hypoxic cell markers","volume":"167","author":"Ljungkvist","year":"2007","journal-title":"Radiat Res"},{"key":"10.1016\/j.radonc.2017.08.010_b0245","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0014-2964(68)90015-7","article-title":"Tumour reoxygenation during fractionated radiotherapy; studies with a transplantable mouse osteosarcoma","volume":"4","author":"Van Putten","year":"1968","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2017.08.010_b0265","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.ijrobp.2011.02.015","article-title":"Exploratory study of the prognostic value of microenvironmental parameters during fractionated irradiation in human squamous cell carcinoma xenografts","volume":"80","author":"Yaromina","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2017.08.010_b0285","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2012.08.019","article-title":"Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer","volume":"105","author":"Zips","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.08.010_b0190","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.nucmedbio.2005.03.010","article-title":"Fully automated one-pot synthesis of [18F]fluoromisonidazole","volume":"32","author":"Tang","year":"2005","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.radonc.2017.08.010_b0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3413\/nukmed-00328-10-07","article-title":"Two or four hour [(1)(8)F]FMISO-PET in HNSCC. When is the contrast best?","volume":"50","author":"Abolmaali","year":"2011","journal-title":"Nuklearmedizin"},{"key":"10.1016\/j.radonc.2017.08.010_b0210","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-2407-5-152","article-title":"Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer","volume":"5","author":"Thorwarth","year":"2005","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2017.08.010_b0070","series-title":"Workshop on Tomography, data processing and image reconstruction for medicine and engineering","article-title":"A modular software system for image analysis in positron emission tomography","author":"Haase","year":"2012"},{"key":"10.1016\/j.radonc.2017.08.010_b0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3413\/Nukmed-0419-11-07","article-title":"Automatic volume delineation in oncological PET. Evaluation of a dedicated software tool and comparison with manual delineation in clinical data sets","volume":"51","author":"Hofheinz","year":"2012","journal-title":"Nuklearmedizin"},{"key":"10.1016\/j.radonc.2017.08.010_b0175","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1007\/s00259-014-2730-x","article-title":"A prospective clinical study of (1)(8)F-FAZA PET-CT hypoxia imaging in head and neck squamous cell carcinoma before and during radiation therapy","volume":"41","author":"Servagi-Vernat","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.radonc.2017.08.010_b0280","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.radonc.2013.08.031","article-title":"Hypoxia imaging with [(1)(8)F]HX4 PET in NSCLC patients: defining optimal imaging parameters","volume":"109","author":"Zegers","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.08.010_b0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2017.08.010_b0145","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.radonc.2014.11.011","volume":"113","author":"Lohaus","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.08.010_b0150","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1470-2045(10)70017-6","article-title":"HPV-associated head and neck cancer: a virus-related cancer epidemic","volume":"11","author":"Marur","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2017.08.010_b0140","first-page":"255","article-title":"HPV and beyond-looking out for biomarkers for distinguishing the good prognosis from the bad prognosis group in locally advanced and clinically high risk HNSCC","volume":"3","author":"Lohaus","year":"2015","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.radonc.2017.08.010_b0080","series-title":"Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis","author":"Harrell","year":"2001"},{"key":"10.1016\/j.radonc.2017.08.010_b0020","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.radonc.2014.10.010","article-title":"Dynamics of tumor hypoxia assessed by 18F-FAZA PET\/CT in head and neck and lung cancer patients during chemoradiation: possible implications for radiotherapy treatment planning strategies","volume":"113","author":"Bollineni","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.08.010_b0025","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.2967\/jnumed.115.155309","article-title":"Prognostic value of pretherapeutic tumor-to-blood standardized uptake ratio in patients with esophageal carcinoma","volume":"56","author":"Butof","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.radonc.2017.08.010_b0030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.radonc.2012.03.001","article-title":"Can \u201cearly\u201d and \u201clate\u201d 18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy?","volume":"103","author":"Castaldi","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.08.010_b0035","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/hed.20629","article-title":"Clinical impact of, and prognostic stratification by, F-18 FDG PET\/CT in head and neck mucosal squamous cell carcinoma","volume":"29","author":"Connell","year":"2007","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2017.08.010_b0060","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.lungcan.2015.09.016","article-title":"The impact of respiratory gated positron emission tomography on clinical staging and management of patients with lung cancer","volume":"90","author":"Grootjans","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2017.08.010_b0085","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00259-011-1759-3","article-title":"Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer","volume":"38","author":"Hentschel","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.radonc.2017.08.010_b0115","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/01.sla.0000208430.07050.61","article-title":"Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer","volume":"243","author":"Levine","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.radonc.2017.08.010_b0240","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.2967\/jnumed.112.116921","article-title":"18F-FDG PET early response evaluation of locally advanced non-small cell lung cancer treated with concomitant chemoradiotherapy","volume":"54","author":"Usmanij","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1016\/j.radonc.2017.08.010_b0255","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.radonc.2015.09.015","article-title":"Serial [18F]-fluoromisonidazole PET during radiochemotherapy for locally advanced head and neck cancer and its correlation with outcome","volume":"117","author":"Wiedenmann","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.08.010_b0130","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.radonc.2016.11.008","volume":"121","author":"Linge","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.08.010_b0065","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ijrobp.2007.05.079","article-title":"Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer","volume":"69","author":"Grosu","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2017.08.010_b0290","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3109\/0284186X.2015.1074720","article-title":"Spatial distribution of FMISO in head and neck squamous cell carcinomas during radio-chemotherapy and its correlation to pattern of failure","volume":"54","author":"Zschaeck","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2017.08.010_b0225","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2006.07.023","article-title":"Imaging hypoxia after oxygenation-modification: comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors","volume":"80","author":"Troost","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.08.010_b0230","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s00259-008-0772-7","article-title":"Correlation of [(18)F]FMISO autoradiography and pimonodazole immunohistochemistry in human head and neck carcinoma xenografts","volume":"35","author":"Troost","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.radonc.2017.08.010_b0260","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.radonc.2005.06.019","article-title":"Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma?","volume":"76","author":"Yaromina","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.08.010_b0215","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0167-8140(15)30422-9","article-title":"Validation of a hypoxia TCP model and dose painting in HNC: planned interim analysis of a phase II trial","volume":"111","author":"Thorwarth","year":"2014","journal-title":"Radiother Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814017325173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814017325173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T09:23:26Z","timestamp":1656235406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814017325173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0167814017325173"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2017.08.010","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Residual tumour hypoxia in head-and-neck cancer patients undergoing primary radiochemotherapy, final results of a prospective trial on repeat FMISO-PET imaging","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2017.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}